Condition: Erythromelalgia · Sponsor: St. Olavs Hospital
Erythromelalgia is a rare disorder characterized by red, warm, and painful extremities, which is often precipitated by warm conditions. The pathophysiology is incompletely understood. The management of pain in erythromelalgia is challenging as no single therapy has been found to be effective. Response to pharmacotherapy varies, meaning that the physician has to take a stepwise trial and error approach with each patient. Consequently, this disorder is often associated with poorer health-related quality of life. There is currently no consensus or guideline on management of pain in erythromelalgia. Spinal cord stimulation is a widely applied therapy to treat severe chronic pain of various origin. Case reports and anecdotal evidence suggest that this therapy might alleviate refractory pain in patients with erythromelalgia. The aim of this trial is to evaluate the efficacy of spinal cord stimulation for refractory pain in erythromelalgia.
This description comes directly from the study's public registry record.
Sasha Gulati, md prof · +47 73592020 · sasha.gulati@ntnu.no
Sven M Carlsen, md prof · +47 91769528 · sven.carlsen@ntnu.no
Always discuss trial participation with your own doctor first.
| Halden Dermatology Center | Halden, Norway | Recruiting |
| Aleris | Strømmen, Norway | Recruiting |
| Universitetssykehuset nord-norge hf | Tromsø, Norway | Recruiting |
| St Olavs Hospital | Trondheim, Norway | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04039633